Correlation Between Regeneron Pharmaceuticals and Encore Capital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Encore Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Encore Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Encore Capital Group, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Encore Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Encore Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Encore Capital.

Diversification Opportunities for Regeneron Pharmaceuticals and Encore Capital

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Regeneron and Encore is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Encore Capital Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Encore Capital Group and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Encore Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Encore Capital Group has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Encore Capital go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Encore Capital

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Encore Capital. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 1.0 times less risky than Encore Capital. The stock trades about -0.43 of its potential returns per unit of risk. The Encore Capital Group is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  4,708  in Encore Capital Group on August 28, 2024 and sell it today you would earn a total of  193.00  from holding Encore Capital Group or generate 4.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy97.67%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  Encore Capital Group

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Encore Capital Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Encore Capital Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Encore Capital is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Regeneron Pharmaceuticals and Encore Capital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and Encore Capital

The main advantage of trading using opposite Regeneron Pharmaceuticals and Encore Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Encore Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Encore Capital will offset losses from the drop in Encore Capital's long position.
The idea behind Regeneron Pharmaceuticals and Encore Capital Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing